Epygenix Therapeutics announces FDA acceptance of IND to initiate clinical trial of EPX-100 to treat LGS Read more
NRx Pharmaceuticals announces positive safety report for Zyesami in NIH-sponsored ACTIV-3 study in COVID-19 patients Read more
NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms Read more